المؤلفون: White, H.D. (Harvey), Steg, P.G. (Philippe Gabriel), Szarek, M., Bhatt, D.L. (Deepak), Bittner, V.A., Díaz, R. (Rafael), Edelberg, J.M., Erglis, A. (Andrejs), Goodman, S.G., Hanotin, C., Harrington, R.A. (Robert Alex), Jukeme, J.W. (J. Wouter), Lopes, R.D., Mahaffey, K.W. (Kenneth), Moryusef, A., Pordy, R., Roe, M.T. (Matthew), Sritara, P., Tricoci, P, Simoons, M.L. (Maarten), Sijbrands, E.J.G. (Eric), Zeiher, A.M. (Andreas), Schwartz, G.G. (Gregory)

المصدر: European Heart Journal vol. 40 no. 33, pp. 2801-2809

مصطلحات موضوعية: Alirocumab • Prevention • MI types • Mortality

وصف الملف: application/pdf

العلاقة: http://repub.eur.nl/pub/127137Test; urn:hdl:1765/127137

الإتاحة: https://doi.org/10.1093/eurheartj/ehz299Test
http://repub.eur.nl/pub/127137Test

مصطلحات الفهرس: Alirocumab • Prevention • MI types • Mortality, info:eu-repo/semantics/article

URL: http://repub.eur.nl/pub/127137Test